For many people, FM and CFS/ME remain a mystery. It's only through the efforts of doctors
and researchers that we've been able to reveal what we know thus far about these
This section spotlights some of the top people who are involved
in FM and/or CFS/ME research. Select the doctor you'd like to learn more about by
clicking their name in the list below.
Medical Researchers (in alphabetical order)
Charles Lapp, M.D.
John C. Lowe, M.D.
Benjamin Natelson, M.D.
Daniel L. Peterson, M.D.
Richard Podell, M.D.
Jacob Teitelbaum, M.D.
Muhammad B. Yunus, M.D.
Lucinda Bateman, M.D.
Dr. Lucinda Bateman completed her BS and MS at Brigham Young University (BYU), attended
the John Hopkins School of Medicine, returned to the University of Utah for Internal
Medicine residency, and became certified by the American Board of Internal Medicine in
1991. She started a small private group practice in 1991 and practiced General Internal
Medicine until 2000.
During this time, she proctored many students as Adjunct Volunteer Clinical Faculty for
the University of Utah, including nurse practitioners, physician assistants (PA), medical
students and residents, and was active on the staff at LDS Hospital. She was awarded
Teacher of the Year four times while teaching in the Utah PA (Physician's Assistant)
program. In 2000, she was one of three Utah internists chosen by her peers in Top
Doctors, a national publication.
Dr. Bateman has served on the boards of the Easter Seals of Utah, International
Association of Chronic Fatigue Syndrome (IACFS/ME) and The CFIDS Association of America.
She is the co-founder and current Executive Director of OFFER (The Organization for
Fatigue Education and Research). Throughout her career, her interest has gradually
become more focused on the diagnosis and management of unexplained chronic fatigue,
CFS/ME and FM, inspired in part by the silent suffering of her sister, Shauna Bateman
Horne, who had CFS for 15 years before she was diagnosed with non-Hodgkins lymphoma in
2000 and died from complications of a stem cell transplant in May of 2001.
In 2000, Dr. Bateman opened her fatigue consultation clinic and has since evaluated more
than 1000 patients with chronic fatigue. She has lectured extensively on issues relating
to chronic fatigue syndrome and fibromyalgia. Dr. Bateman's goal in establishing her
fatigue consultation clinic and the non-profit organization OFFER is to encourage a more
thoughtful evaluation process, sharing of information with patients and medical
providers, and cooperative research efforts aimed at understanding the cause(s) of
CFS/ME and FMS.
David S. Bell, M.D.
David S. Bell, MD graduated from Harvard College in 1967 with an AB degree in English
literature followed by Boston University with an MD degree in 1971. Post doctoral
training in pediatrics was completed in 1976 with subspecialty training in Pediatric
Behavior and Developmental Disorders. In 1978 he began work at the University of
Rochester but soon began a private practice in the town of Lyndonville, New York.
In 1985 nearly 220 persons became ill with an illness subsequently called chronic
fatigue syndrome in the communities surrounding Lyndonville, New York. This illness
cluster began a study of the illness which continues today. Dr. Bell is the author or
co-author of numerous scientific papers on CFS, and, in 2003 was named Chairman of the
Advisory Committee for Chronic Fatigue Syndrome of the Department of Health and Human
Services. Publications include A Disease of A Thousand Names, (1988) and The
Doctor's Guide to Chronic Fatigue Syndrome, (1990).
Dr. Bell currently practices general medicine in Lyndonville, New York with his wife
Nancy, a family nurse practitioner. Roughly half of the patients seen in the practice
suffer from chronic fatigue syndrome, fibromyalgia, orthostatic intolerance, and/or
myalgic encephalomyelitis. His webiste address is: http://www.davidsbell.com.
Paul R. Cheney, M.D., Ph.D.
Dr. Paul Cheney, MD, PhD, is Medical Director of the
Cheney Clinic in Asheville, North Carolina.
For more than 25 years, Dr. Cheney has been a pioneering clinical researcher in the field
of ME/CFS and has been an internationally recognized authority on the subject of ME/CFS.
He has published numerous articles and lectured around the world on ME/CFS.
Dr. Cheney has been interested in many aspects of ME/CFS, and is author or co-author of
numerous publications and scientific presentations in a range of fields relevant to the
While practicing in Lake Tahoe in 1984-1987, Dr. Cheney, along with Dr. Dan Peterson,
helped lead a research effort with the NIH, the CDC and Harvard University School of
Medicine studying a localized outbreak of what would eventually be known as ME/CFS.
He was a founding Director of the American Association of CFS (now the International
Association for CFS/ME).
Dr. Cheney holds a PhD in Physics from Duke University in Durham, NC and is a graduate
(MD) of Emory University School of Medicine in Atlanta, GA where he also completed his
internal medicine residency. He is a board certified internist.
More recently, Dr. Cheney has been engaged in investigating the cardiac function of CFS
patients, using Impedance Cardiography and Doppler Echocardiography. According to his
paper presented at the 2007 IACFS/ME conference, "Chronic Fatigue Syndrome patients
exhibit evidence of diastolic dysfunction at a level well above that reported for control
populations of the same age. Energy dependent diastolic dysfunction would appear to be a
hallmark of CFS and supports the hypothesis that CFS is a syndrome of cellular energy
Since 1990, Dr. Cheney has headed the Cheney Clinic, presently located in Asheville, NC.
The Cheney Clinic specializes in evaluating CFS patients and has expertise in diagnosis,
disability support for and treatment of chronic fatigue syndrome. No single clinic has
drawn as many CFS patients (currently over 5,000) from as many states (48) and foreign
countries (22) as has the Cheney Clinic.
The Cheney Clinic has evaluated over 8,000 patients from 48 states and 24 foreign
countries and participated in an FDA-approved multi-center, a biological response
pharmaceutical drug trial using Ampligen, a biological response modifier.
Daniel J. Clauw, M.D.
Doctorate in Rheumatology, 1990, from Georgetown University Medical Center.
Professor, Department of Internal Medicine at the University of Michigan. He has
served on the faculty at Michigan University since April 8, 2003.
Dr. Daniel J. Clauw oversees a multidisciplinary group that performs both mechanistic
studies and clinical trials in overlapping conditions characterized by chronic pain
and fatigue, including fibromyalgia, chronic fatigue syndrome, and Gulf War Illnesses.
Dr. Clauw has been the P. I. of NIH and Department of Defense grants studying this spectrum
of illness continuously since 1994. The Center currently has several million dollars per
year in federal funding to study these disorders. Dr. Clauw and his group have
been instrumental in establishing that the systemic conditions noted above, and regional
pain syndromes such as interstitial cystitis, low back pain, and irritable bowel
syndrome all have common pathogenic and clinical features.
One of the primary areas of interest of his group has been in studying sensory processing
in these conditions, and in demonstrating that many patients with these conditions have
a widespread disturbance in pain processing. Current work is establishing the nature of
the central pain processing abnormality in these conditions, using a variety of
approaches, including functional MRI. Dr. Clauw also directs the Center for the Advancement
of Clinical Research (CACR) at the University of Michigan. The CACR provides
infrastructure and support for clinical and translational research for the Medical School
from protocol development through subject recruitment, performance, and monitoring of
study conduct, to data management and analysis.
Garry F. Gordon, M.D.
Dr. Garry F. Gordon received his Doctor of Osteopathy in 1958 from the Chicago College
of Osteopathy in Illinois. He received his honorary MD degree from the University
of California Irvine in 1962 and completed his Radiology Residency from Mt. Zion in
San Francisco, California in 1964. For many years, he was the Medical Director of
Mineral Lab in Hayward, California, a leading laboratory for trace mineral analysis
Dr. Gordon is on the Board of Homeopathic Medical Examiners for Arizona and is Co-Founder
of the American College for Advancement in Medicine (ACAM). He is Founder/President of
the International College of Advanced Longevity (ICALM) and Board Member of
International Oxidative Medicine Association (IOMA).
Leonard A. Jason, PhD
B. A. in Psychology from Brandeis University, Waltham, Massachusetts, 1971. Ph.D.
in Clinical/Community Psychology from the University of Rochester, Rochester, New York,
1975. Dr. Jason is Director of the Center for Community Research at De Paul University.
In 2001, the Center for Community Research was established at De Paul University to
provide permanent, dedicated space for externally funded research projects and
to house research projects of colleagues associated with their work from Psychology and
Currently their grants are from NIH (NIDA, NIAID, NCI) and are devoted to CFS epidemiology,
Smoking Prevention, and Oxford House evaluations. They believe that this is a service to
De Paul University and the Psychology Department, as their grant activity brings in
considerable resources to the university and helps support graduate students. In addition,
there are many undergraduate volunteers for these projects, and frequently they are able to
hire these students to become full time research assistants, which prepares them for future
Charles Lapp, M.D.
B. A. and M.A. in Engineering from Rensselaer Polytechnic Institute, Troy, N. Y. Earned
his M.D. degree from Albany Medical College, NY, in 1974. Dr. Lapp completed residencies
in both adult (internal) medicine and pediatrics at the University of North Carolina at
Dr. Lapp has maintained a private practice of medicine and pediatrics in Raleigh, NC.
since 1978. Following three small epidemics of a chronic fatiguing illness in the
Raleigh area, Dr. Lapp began collaborating with Dr. Paul Cheney in 1987, and from 1992
to 1980. Dr. Lapp acted as Medical Director of the Cheney Clinic in Charlotte. In
August 1980, Dr. Lapp opened a Charlotte office for general medical consultations,
with special interests in Chronic Fatigue Syndrome, Fibromyalgia, and related conditions.
Academically, Dr. Lapp has been elected to Tau Beta Pi (the engineering equivalent of Phi
Beta Kappa) and was a Richard T. Beebe Scholar of Medicine; he has been on the
clinical faculty at the University of North Carolina School of Medicine, was a
pediatrics instructor at Wake Medical Center (Raleigh), and has continued as
Clinical Associate Professor of Family and Community Medicine at Duke University since
1982. He is a diplomat of the American Board of Internal Medicine as well as the
American Board of Pediatrics; he is a Fellow of the American Academy of Pediatrics,
the American Academy of Family Physicians, and the American Academy of Disability
In September 2003, Dr. Lapp was appointed by DHHS Secretary Tommy Thompson to serve on the
CFS Advisory Committee. This committee meets in Washington quarterly to provide expert
advice and recommendations to the Secretary of Health and Human Services on a broad range
of issues and topics pertaining to chronic fatigue syndrome.
Dr. Lapp is nationally recognized as a medical consultant to industry and the
medical profession. He has written numerous articles on diverse subjects, and has
spoken widely, especially concerning Chronic Fatigue Syndrome and Fibromyalgia. He is
active in both civic and professional activities, the state and county medical societies,
as well as the American Medical Association and the Academy of Family Physicians. He is
an active Rotarian, former president of the Muscular Dystrophy Association, and as a
Jaycee was nominated Outstanding Man of the Year in 1983. In 1985, the Department of
Family and Community Medicine at Duke University voted him Clinical Professor of the
Year. Dr. Lapp is a board member of the American Association for CFS and the
American Fibromyalgia Syndrome Association, advisor to ProHealth Incorporated, medical
advisor to the CFIDS Association of America and a member of the Scientific Advisory
Nancy Klimas, M.D.
Dr. Klimas, a director of the laboratory, is board certified in internal medicine and
diagnostic laboratory immunology. She is also the director of the Allergy and Immunology
Clinic, and is a licensed laboratory director in Florida. Dr. Klimas is Director of
Research for the Clinical AIDS/HIV Research at the Miami Veterans Affairs Medical Center.
A leader in the field of Chronic Fatigue Syndrome (CFS) research, Dr. Klimas is the
current President of the International Association for Chronic Fatigue Syndrome. Dr.
Klimas is the principal investigator of the National Institute of Health's (NIH) Center
for Multidisciplinary Studies of CFS Pathophysiology at the University of Miami. Dr.
Klimas has been appointed to the inter-agency CFS Coordinating Committee, chaired by the
Surgeon General of the United States. She is the founding editor of the Journal of
Chronic Fatigue Syndrome. Recent publications include 123 peer reviewed papers, 3 books
and 19 invited chapters.
John C. Lowe, M.D.
Dr. Lowe holds B. A. and M.A. degrees in research-oriented general psychology from
the University of West Florida. He also holds a B. S. degree in human biology and a
doctorate in chiropractic from the Los Angeles College of Chiropractic, now the
Southern California University of Health Sciences. He formerly taught psychology at the
Miami Dade Community College and was a faculty member in the Clinical Sciences Division
of the Texas Chiropractic College. Dr. John C. Lowe, a fibromyalgia, thyroid, and
metabolism researcher, is a board certified pain management specialist.
As Director of Research for the Fibromyalgia Research Foundation, he has spearheaded
the scientific study of two related subjects: the metabolic causes of fibromyalgia, and
the relief of fibromyalgia symptoms through the treatment approach he developed and
named "metabolic rehabilitation." He is author of the internationally acclaimed book,
The Metabolic Treatment of Fibromyalgia, considered by many to be the most
important document ever published on fibromyalgia. He has authored more than 140
articles, scientific papers, and book chapters. His writings have appeared in many of the
top medical journals.
In 1980, one of Dr. Lowe's patients who had recovered from their fibromyalgia symptoms
through his metabolic approach convinced him to established the Fibromyalgia
Research Foundation (FRF). The three purposes of this 501(c)(3) nonprofit organization
are to: (1) support scientific studies of the metabolic treatment of fibromyalgia
patients; (2) determine the underlying molecular mechanisms of fibromyalgia; and (3)
educate fibromyalgia patients, health care practitioners, researchers, and the general
public about the findings of FRF-sponsored research.
Currently, Dr. Lowe and his multidisciplinary research team are studying the metabolic
rates of fibromyalgia patients. In two studies that will soon be published, he and
his colleagues found that fibromyalgia patients have abnormally low metabolic rates
compared to healthy controls. Results of these studies vindicate Dr. Lowe's hypothesis
that fibromyalgia patients are hypometabolic, and that the most likely mechanism is too
little thyroid hormone regulation.
Benjamin Natelson, M.D.
Dr. Natelson attended the University of Pennsylvania in Philadelphia for both his
undergraduate and medical degrees. He then trained in neurology at the Albert Einstein
College of Medicine in the Bronx. He received additional post-doctoral training in
Behavioral Medicine (the science of how stress influences disease) at Cornell
University's New York Hospital and at the Walter Reed Institute of Research in
Washington DC. Thereafter he moved to New Jersey to UMDNJ where he advanced through the
ranks to Professor of Neurology and Neurosciences.
Currently he holds the title of Emeritus Professor of Neurology and Neurosciences at
UMDNJ and a new title of Professor of Neurology at at the Albert Einstein College of
Medicine, the medical school associated with BIMC.
The Pain & Fatigue Study Center, located at
Suite 2R, 10 Union Square East, New York, NY 10003, provides an
integrated approach to patient care and scientific research headed by Dr. Benjamin
Natelson, M.D. The Center's integrated approach to clinical care and research is based
on providing comprehensive treatment to those who experience medically unexplained pain
and fatigue and continuing to do clinical research supported by the National Institutes
of Health and by the pharmaceutical industry.
Daniel L. Peterson, M.D.
Dr. Peterson is physician in private practice in the state of Nevada, and has been
described as a "pioneer" in the treatment of chronic fatigue syndrome (CFS). He
graduated from the University of Rochester School of Medicine, Rochester, New York,
in 1976 and was an intern and resident at the University of Utah Medical Center from
1976-1979. In 1979 he became a Diplomat of the American Board of Internal Medicine.
He is president of Sierra Internal Medicine of Incline Village, established in 1981.
Along with Paul Cheney, Peterson was a treating physician at Incline Village during an
outbreak of chronic fatigue syndrome that began in 1984 in the Lake Tahoe region. From
1984 to 1987, the illness was recorded in 259 patients in the area by the two physicians.
The Lake Tahoe outbreak became the subject of several studies by Peterson and others. In
1995, Peterson and other investigators started conducting a 10-year follow-up study on
patients seen during the outbreak. The study results were published in 2001 by the
Journal of Chronic Fatigue Syndrome. In the 2000 CFS documentary
I Remember Me, Peterson was interviewed about some of his experiences during
the Lake Tahoe outbreak.
In 1988, Peterson was the first physician to treat an extremely ill person diagnosed
with CFS with the experimental drug Ampligen by obtaining compassionate-use permission
from the U.S. Food and Drug Administration. Quantitative improvement in the first patient
enabled the next pilot study of Ampligen in CFS patients by Peterson and other
researchers. During the 1990 CFIDS Conference in Charlotte, North Carolina, Peterson
described positive results in 15 CFS patents after he treated them with Ampligen for
approximately 6 months. In 1990 and 1991, Peterson was one of four principal
investigators for the FDA approved phase II randomized placebo controlled double-blind
study of the experimental intravenous drug Ampligen. The drug was administered in his
Incline Village facility and three other sites. Peterson and others reported that there
was statistically significant improvement in the patients receiving Ampligen. He is a
principal investigator of the FDA-approved open-label safety and efficacy phase III drug
study of Ampligen for treatment of chronic fatigue syndrome. Hemispherx Biopharma's New
Drug Application for marketing and sale of Ampligen to treat chronic fatigue syndrome was
rejected in December 2009 because the FDA concluded that the two RCTs "did not provide
credible evidence of efficacy."
Peterson was a member of the International Chronic Fatigue Syndrome Study Group that
coauthored the most widely used clinical and research description of CFS, called the
1994 CDC definition, and the Fukuda definition. He is a coauthor of Myalgic
Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic
and Treatment Protocols, initiated by Health Canada and published by an international
group of researchers in 2003.
Peterson, along with Annette and Harvey Whittemore, helped establish the Whittemore
Peterson Institute for Neuro-Immune Disease at the University of Nevada in 2005 to aid
patients with chronic fatigue syndrome, fibromyalgia and related illnesses.
In October 2009 Peterson was interviewed on National Public Radio about his views on
chronic fatigue syndrome and the possible association with the retrovirus XMRV.
On September 22, 2011, Science published online a
nine-lab study widely seen as the final
blow to the theory, championed by Mikovits and colleagues in an
October 2009 Science paper, that a recently detected
mouse retrovirus might play a causal role in chronic fatigue syndrome (CFS). A letter in
the same issue of Science from one of the contributing labs to the 2009 report revealed
that a contamination had marred its contribution-PCR detection and sequencing of the mouse
virus, dubbed XMRV. Mikovits and colleagues defended the validity of the rest of the
study, known as Lombardi et al., which detected the virus by several other methods, so
issued a rare partial retraction of the
original paper. Mikovits was fired from Whittemore Peterson Institute on
September 29, 2011.
Richard Podell, M.D.
A graduate of Harvard Medical School and the Harvard School of Public Health, Dr. Podell
is Board Certified in Internal Medicine and in Family Medicine. A Clinical Professor at
New Jersey's Robert Wood Johnson Medical School, Dr. Podell serves as co-host of the
Willner's Window Health and Nutrition Show on New York City's WOR Radio (710 AM).
Richard N. Podell, M.D., M.P.H., Medical Director and Clinical Professor, Department
of Family Medicine, UMDNJ-Robert Wood Johnson Medical School.
Dr. Podell is one of the nation's leading experts on the scientific integration
of complementary and alternative therapies with conventional medicine. He also has
special interest and expertise in clinical nutrition, behavioral medicine, and the diseases
of Chronic Fatigue Syndrome and Fibromyalgia.
The New Jersey Chronic Fatigue Syndrome Association presented Dr. Podell with
their outstanding Achievement Award for the year 2002. Dr. Podell serves as
Principal Investigator of a Food and Drug Administration approved Phase III clinical
trial on the use of Ampligen, an investigational drug for the treatment of Chronic
Fatigue Syndrome. He is a member of the expert panel on Chronic Fatigue Syndrome for the
New Jersey State Department of Health and the New Jersey Academy of Medicine. He is a
member of the Chronic Fatigue Syndrome Association, the International Myopain Society,
the American College of Nutrition and the American Medical Association.
Dr. Podell has been an invited author for Fibromyalgia Network, a major
patient-advocacy support group. Dr. Podell has served as one of the main preceptors
for Robert Wood Johnson Medical School's required third year course on nutritional
and holistic medicine. Dr. Podell has received teaching awards from the family
practice residents at Overlook Hospital and from the medical student organization at
New Jersey Medical School.
Dr. Podell is on the scientific advisory board of Healthnotes, one of the leading
educational resources for the scientific evaluation of nutrition and herbal therapies.
He was contributing editor for Nutrition Science News, and was the regular columnist
on nutrition for the journal Postgraduate Medicine. Dr. Podell has published 45
peer-review journal articles, and patient education essays in Bottom Line Personal,
Bottom Line Health, Redbook, Good Housekeeping, Men's Health and other magazines.
He has appeared as a medical expert on Good Morning America, the Today Show and CBS'
Morning Show. Dr. Podell is an attending physician at Overlook Hospital, Summit, NJ.
Jacob Teitelbaum, M.D.
Dr. Teitelbaum is a board certified internist and Medical Director of the
national Fibromyalgia and Fatigue Centers, Inc. He is the author of the perennial
best-seller From Fatigued to Fantastic!, which has sold over 500,000 copies. The 3rd
revised edition from Avery/Penguin Group USA publishes on October 4, 2007.
In Pain Free 1-2-3 (McGraw-Hill, April 2006), Dr. Teitelbaum outlines a step-by-step
program that can help anyone identify the source of pain and understand how to alleviate
it. Three Steps to Happiness: Healing Through Joy (Deva Press 2003), provides a blueprint
for creating and maintaining a natural state of happiness and vitality at any time.
Dr. Teitelbaum lectures to patient, physician and research groups internationally. He is
the lead author of groundbreaking "gold standard" research on effective treatment for
Chronic Fatigue Syndrome and Fibromyalgia, which was published in the Journal of
Chronic Fatigue Syndrome, volume 8, number 2 in 2001.
In April 2002, he was editorialized in the Journal of the American Academy of Pain
Management, where his integrative treatment protocol was recognized as "standard of
practice" for chronic pain conditions.
His latest study published in the Journal of Alternative and Complementary Medicine focused
on the effects of a unique 5-carbon sugar called D-ribose for Fibromyalgia patients.
The research found that 2/3 of the patients studied showed improvement after only 12 days
of therapy. The average increase in energy was 45 percent, with an average 30
percent improvement in well-being. Corvalen, a proprietary D-ribose product of Bioenergy
Life Science, Inc., is designed to improve the metabolic health of hearts and muscles and
is used to provide nutritional support to sufferers of Fibromyalgia, Chronic Fatigue
Syndrome (CFS), and cardiovascular disease.
Dr. Teitelbaum knows CFS/Fibromyalgia as an insider -- he contracted Chronic Fatigue
Syndrome when he was in medical school and had to drop out for a year to recover. In
the ensuing 25 years, he dedicated his career to finding effective treatment.
His web site (http://www.endfatigue.com) contains a sophisticated computer
program, which can analyze and create a complete medical record of a patient's case to
help patients and physicians determine the best course of treatment to get well.
Muhammad B. Yunus, M.D.
Medical Training - University of Dhaka, Bangladesh, Residency Training - United
Kingdom Fellowship Training - University of Massachusetts Medical School, Worchester,
and University of Illinois College of Medicine at Peoria. Professor of Medicine
and Rheumatology, Internal Medicine Residency Program. Director, sophomore
musculoskeletal and connective tissue disease course; didactic Rheumatology seminar series
for residents, bedside teaching during management and teaching rounds; M3 case
reports, seminars on physical diagnosis in Rheumatology patients.
Author of over 130 articles and publications, Dr. Yunas has made significant contributions
in describing, characterizing and defining fibromyalgia syndrome (FMS), and remains active
in the research of this condition. He is particularly interested in the enuroendocrine
aspects of FMA and similar syndromes with chronic pain. He enjoys working in
investigational study design and writing, including literary writing.